Li M., Zhao C., Xiang H., Wang Y., Gao R., Cai Q., Chen Q., Chen Z., Hu L., Li Q. Design, synthesis and optimization of pyrazolo[3,4-b] pyridine derivatives as Hsp110-STAT3 interaction disruptors for the treatment of pulmonary arterial hypertension. Bioorg Chem, 2024, 153: 107888.
上一条:Li J., Gao R., Zhao C., Xiang H., Le X., Zhang X., Cai Q., He L., Li Q., Hu L., Zou H. Inhibition of breast cancer growth with AN-329, a novel Hsp110 inhibitor, by inactivating p-STAT3/c-Myc axis. Biomed. Pharmacother., 2024, 181: 117694.
下一条:Wang Z., Liu L., Liu E., Chen R., Huang Y., Li Q. Carrier Polymer-Free Dissolvable Microneedles Enable Superhigh Drug Payload for Percutaneous Protein Delivery. ACS Materials Letters, 2024, 6(11): 4980-4987.